FDA Wary Of Wider Use For Abbott's Humira
Abbott Laboratories could be facing another setback in efforts to win approval for wider use of blockbuster biologic medicine Humira after U.S. Food and Drug Administration researchers on Friday questioned the...To view the full article, register now.
Already a subscriber? Click here to view full article